Coastal Bridge Advisors LLC Has $730,000 Stock Position in Zoetis Inc. $ZTS

Coastal Bridge Advisors LLC lessened its position in shares of Zoetis Inc. (NYSE:ZTS) by 85.3% in the third quarter, according to its most recent filing with the SEC. The firm owned 4,991 shares of the company’s stock after selling 28,875 shares during the quarter. Coastal Bridge Advisors LLC’s holdings in Zoetis were worth $730,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC lifted its holdings in Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after buying an additional 2,978 shares during the period. Empowered Funds LLC lifted its stake in shares of Zoetis by 6.2% in the 1st quarter. Empowered Funds LLC now owns 11,293 shares of the company’s stock valued at $1,859,000 after purchasing an additional 657 shares during the period. Intech Investment Management LLC boosted its position in shares of Zoetis by 17.2% during the 1st quarter. Intech Investment Management LLC now owns 8,347 shares of the company’s stock valued at $1,374,000 after purchasing an additional 1,224 shares in the last quarter. Sivia Capital Partners LLC grew its stake in Zoetis by 73.8% during the second quarter. Sivia Capital Partners LLC now owns 3,348 shares of the company’s stock worth $522,000 after purchasing an additional 1,422 shares during the period. Finally, Sound Income Strategies LLC grew its stake in Zoetis by 54.3% during the second quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock worth $67,000 after purchasing an additional 152 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on ZTS shares. KeyCorp initiated coverage on Zoetis in a report on Thursday, November 20th. They set a “sector weight” rating on the stock. Morgan Stanley set a $160.00 target price on shares of Zoetis in a research note on Thursday, December 18th. Weiss Ratings downgraded shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday. Barclays started coverage on shares of Zoetis in a report on Monday, December 8th. They set an “equal weight” rating and a $136.00 price objective on the stock. Finally, UBS Group set a $136.00 target price on Zoetis in a research note on Thursday. Five equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $152.45.

Zoetis Stock Down 0.2%

Zoetis stock opened at $121.63 on Friday. The firm has a market capitalization of $53.60 billion, a price-to-earnings ratio of 20.48, a price-to-earnings-growth ratio of 2.11 and a beta of 0.97. The firm’s fifty day moving average price is $124.03 and its two-hundred day moving average price is $137.47. Zoetis Inc. has a 1-year low of $115.25 and a 1-year high of $177.40. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. During the same period in the previous year, the firm posted $1.58 earnings per share. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities research analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be issued a $0.53 dividend. This is a boost from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio is 35.69%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.